1025919-89-4

Upstream product

• 78-27-3 1-Ethynylcyclohexan-1-ol 
• 1027525-96-7 3-(6-chloro-2-iodo-9-methyl-9H-purin-8-yl)-benzonitrile 
• 24964-64-5 3-Cyanobenzaldehyde 
• 1026421-47-5 3-(2-amino-6-chloro-9-methyl-9H-purin-8-yl)-benzonitrile 
• 1027497-87-5 N-(4-Chloro-5-{[1-(3-cyano-phenyl)-meth-(E)-ylidene]-amino}-6-methylamino-pyrimidin-2-yl)-acetamide 
• 232254-95-4 N₁-[4-chloro-6-(methylamino)-5-nitro-2-pyrimidinyl]acetamide 
• 327161-45-5 N₁-[5-amino-4-chloro-6-(methylamino)-2-pyrimidinyl]acetamide 

Relevant academic research and scientific papers

2-alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: Their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A2B receptor

Novel adenosine antagonists, 2-alkynyl-8-aryl-9-methyladenine derivatives, were synthesized as candidate hypoglycemic agents. These analogues were evaluated for inhibitory activity on N-ethylcarboxamidoadenosine (NECA)-induced glucose production in primar